Daewoong Pharmaceutical

South Korean publicly traded pharma company (KRX: 069620) with peptide-related capabilities including EGF production and peptide delivery technologies. GMP-certified facilities. Primarily a diversified pharma company with API manufacturing and CDMO services spanning small molecules and biologics.

Daewoong Pharmaceutical is listed as a manufacturer in the peptide supply chain, serving Asia markets from South Korea. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.